Solicitation, 8(a) sole source
IDIQ for the purchase of human induced pluripotent stem cell-derived cells
FDASS126983
Food and Drug Administration, FDA Center for Drug Evaluation and Research. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
May 2, 2025 at 10:00 AM EDT
Closed 554 days ago. Posted April 9, 2025. Scheduled to archive May 17, 2025.
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one closed in 2025
16 like it are open now in research and development in biotechnology (except nanobiotechnology)
- Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
National Institutes of Health, Advanced Research Projects Agency for Health (Arpa-H)
SolicitationNAICS 541714Anywhere in the USARPA-H-SOL-26-164Closes in 23 daysNov 30 - Firefox
Defense Advanced Research Projects Agency, Def Advanced Research Projects Agcy
SolicitationNAICS 541714Anywhere in the USDARPA-PS-26-137Closes in 24 daysNov 30 - Pre-Clinical Models of Infectious Diseases
National Institutes of Health, National Institutes of Health Niaid
PresolicitationNAICS 541714Anywhere in the US75N93027R00003Closes in 30 daysDec 7
All 16 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
Notice of Intent to Sole Source Solicitation Number:
FDA - Sole Source - 126983 Posted Date:
April 09, 2025 Questions Due Date:
10AM EST on April 21, 2025 Response Date:
10AM EST May 02, 2025 NAICS Code: 541714-Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
April 9, 2025
Solicitation
Due May 2, 2025 at 10:00 AM EDT. SAM.gov, notice 4a54b7666e5c4f5386a618d79860369e
Points of contact
- Telisha Wilsontelisha.wilson@fda.hhs.gov